Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy
Clinical trial NCT00927914 · COMPLETED
Trial details
- NCT number
- NCT00927914
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2013-01-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.